Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation

British Journal of Ophthalmology

Volumn 97, Issue 3, 2013, Pages 367-370

  Kim, Sang Jin ^a   Kim, Jaeryung ^a   Lee, Jinyoung ^a,b   Cho, Sung Yoon ^a   Kang, Hee Jung ^c   Kim, Ki Yong ^d   Jin, Dong Kyu ^a  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Hallym University   (South Korea)

^d Green Cross Company   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; COMPLEMENT FACTOR H; COMPLEMENT INACTIVATING AGENTS; DISEASE MODELS, ANIMAL; HUMANS; INTRAVITREAL INJECTIONS; LASERS; RATS; RATS, INBRED BN; TREATMENT OUTCOME;

EID: 84874660903     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302307     Document Type: Article

References (25)

1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med 2008;358:2606-17.
2. Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet 2012;379:1728-38.
3. Wong TY, Chakravarthy U, Klein R, et al. The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology 2008;115:116-26.
4. Campochiaro PA, Soloway P, Ryan SJ, et al. The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis 1999;5:34.
5. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004;122:598-614.
6. Donoso LA, Kim D, Frost A, et al. The role of inflammation in the pathogenesis of age-related maculardegeneration. Surv Ophthalmol 2006;51:137-52.
7. Rodrigues EB. Inflammation in dry age-related macular degeneration. Ophthalmologica 2007;221:143-52.
8. Gehrs KM, Jackson JR, Brown EN, et al. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol 2010;128:349-58.
9. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.
10. Edwards AO, Ritter R III, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-4.
11. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005;102:7227-32.
12. Scholl HP, Charbel Issa P, Walier M, et al. Systemic complement activation in age-related macular degeneration. PLoS One 2008;3:e2593.
13. Nitsch D, Douglas I, Smeeth L, et al. Age-related macular degeneration and complement activation-related diseases: a population-based case-control study. Ophthalmology 2008;115:1904-10.
14. Bora PS, Sohn JH, Cruz JM, et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 2005;174:491-7.
15. Bora NS, Kaliappan S, Jha P, et al. Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor H. J Immunol 2006;177:1872-8.
16. Lyzogubov VV, Tytarenko RG, Jha P, et al. Role of ocular complement factor H in a murine model of choroidalneovascularization. Am J Pathol 2010;177:1870-80.
17. Kang HJ, Bao L, Xu Y, et al. Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects. Clin Exp Immunol 2004;136:194-9.
18. Edelman JL, Castro MR. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 2000;71:523-33.
19. Rohrer B, Long Q, Coughlin B, et al. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3056-64.
20. Demberg T, Pollok-Kopp B, Gerke D, et al. Rat complement factor H: molecular cloning, sequencing and quantification with a newly established ELISA. Scand J Immunol 2002;56:149-60.
21. Fakhouri F, de Jorge EG, Brune F, et al. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int 2010;78:279-86.
22. Berkowitz BA, Lukaszew RA, Mullins CM, et al. Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 1998;39:391-7.
23. Hughes A. Aschematic eye for the rat. Vision Res 1979;19:569-88.
24. Weiler JM, Daha MR, Austen KF, et al. Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci USA 1976;73:3268-72.
25. Sim RB, DiScipio RG. Purification and structural studies on the complement-system control protein beta 1H (Factor H). Biochem J 1982;205:285-93.